Using simulation modelling and systems science to help contain COVID‐19: A systematic review
This study systematically reviews applications of three simulation approaches, that is,
system dynamics model (SDM), agent‐based model (ABM) and discrete event simulation …
system dynamics model (SDM), agent‐based model (ABM) and discrete event simulation …
Proteomics-based vaccine targets annotation and design of subunit and mRNA-based vaccines for Monkeypox virus (MPXV) against the recent outbreak
Monkeypox Virus (MPXV) is a growing public health threat with increasing cases and
fatalities globally. To date, no specific vaccine or small molecule therapeutic choices are …
fatalities globally. To date, no specific vaccine or small molecule therapeutic choices are …
Peptide vaccines in melanoma: chemical approaches towards improved immunotherapeutic efficacy
Cancer of the skin is by far the most common of all cancers. Although the incidence of
melanoma is relatively low among skin cancers, it can account for a high number of skin …
melanoma is relatively low among skin cancers, it can account for a high number of skin …
Designing multi-epitope mRNA construct as a universal influenza vaccine candidate for future epidemic/pandemic preparedness
Despite the availability of prevention and treatment strategies and advancing immunization
approaches, the influenza virus remains a global threat that continues to plague humanity …
approaches, the influenza virus remains a global threat that continues to plague humanity …
Immunoinformatics approach to design multi-epitope-based vaccine against machupo virus taking viral nucleocapsid as a potential candidate
The family members of Arenaviridae include members of the genus Machupo virus, which
have bi-segmented negative sense RNA inside the envelope and can be transferred to …
have bi-segmented negative sense RNA inside the envelope and can be transferred to …
In-silico evaluation of adenoviral COVID-19 vaccination protocols: Assessment of immunological memory up to 6 months after the third dose
P Stolfi, F Castiglione, E Mastrostefano… - Frontiers in …, 2022 - frontiersin.org
Background The immune response to adenoviral COVID-19 vaccines is affected by the
interval between doses. The optimal interval is unknown. Aim We aim to explore in-silico the …
interval between doses. The optimal interval is unknown. Aim We aim to explore in-silico the …
Immunoinformatic exploration of a multi-epitope-based peptide vaccine candidate targeting emerging variants of SARS-CoV-2
Many countries around the world are facing severe challenges due to the recently emerging
variants of SARS-CoV-2. Over the last few months, scientists have been developing …
variants of SARS-CoV-2. Over the last few months, scientists have been developing …
SARS-CoV-2 vaccine breakthrough infections (VBI) by Omicron variant (B. 1.1. 529) and consequences in structural and functional impact
Z Abduljaleel, S Melebari, M Athar, S Dehlawi… - Cellular …, 2023 - Elsevier
This study investigated the efficacy of existing vaccines against hospitalization and infection
due to the Omicron variant of COVID-19, particularly for those who received two doses of …
due to the Omicron variant of COVID-19, particularly for those who received two doses of …
Construction and validation of a multi-epitope in silico vaccine model for lymphatic filariasis by targeting Brugia malayi: a reverse vaccinology approach
P Madanagopal, S Muthusamy, SN Pradhan… - Bulletin of the National …, 2023 - Springer
Background Lymphatic filariasis (LF), often referred to as elephantiasis, has been identified
as one of the 17 neglected tropical diseases by the World Health Organization. Currently …
as one of the 17 neglected tropical diseases by the World Health Organization. Currently …
A novel vaccine based on SARS-CoV-2 CD4+ and CD8+ T cell conserved epitopes from variants Alpha to Omicron
I Palatnik-de-Sousa, ZS Wallace, SC Cavalcante… - Scientific reports, 2022 - nature.com
COVID-19 caused, as of September, 1rst, 2022, 599,825,400 confirmed cases, including
6,469,458 deaths. Currently used vaccines reduced severity and mortality but not virus …
6,469,458 deaths. Currently used vaccines reduced severity and mortality but not virus …